Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 110 Records) |
| Query Trace: Pancreatic Neoplasms and BRCA2[original query] |
|---|
| NGS-based targeted gene mutational profiles in Korean patients with pancreatic cancer. Scientific reports 2022 12 12 (1): 20937. Jung Kwangrok, Lee Sejoon, Na Hee Young, Kim Ji-Won, Lee Jong-Chan, Hwang Jin-Hyeok, Kim Jin Won, Kim Jaihw |
| Case report: olaparib use in metastatic lung adenocarcinoma with BRCA2 pathogenic variant. Cold Spring Harbor molecular case studies 2022 12 8 (7): . Soon Jian Hao Jonathan, Hoai Chan Sock, Weng Daniel Tan Shao, Ngeow Joanne, Chiang Jianba |
| BRCA1/2 Reversion Mutations in Patients Treated with Poly ADP-Ribose Polymerase (PARP) Inhibitors or Platinum Agents. Medicina (Kaunas, Lithuania) 2022 12 58 (12): . Darabi Sourat, Braxton David R, Xiu Joanne, Carneiro Benedito A, Swensen Jeff, Antonarakis Emmanuel S, Liu Stephen V, McKay Rana R, Spetzler David, El-Deiry Wafik S, Demeure Michael |
| Mitomycin C in Homologous Recombination Deficient Metastatic Pancreatic Cancer after Disease Progression on Platinum-Based Chemotherapy and Olaparib. Biomedicines 2022 11 10 (11): . Botrus Gehan, Roe Denise, Jameson Gayle S, Junior Pedro Luiz Serrano Uson, Korn Ronald Lee, Caldwell Lana, Bargenquast Taylor, Miller Max, Borazanci Erkut Has |
| Screening Practices for Breast and Nonbreast Cancers in High-Risk Mutation Carriers. The Journal of surgical research 2023 7 291 388-395. Alison C Coogan, Lilia G Lunt, Sarah S Keshwani, Olivia Sandhu, Yanyu Zhang, Cristina O'Donoghue, Andrea Madrigra |
| The Clinical Implications of Reversions in Patients with Advanced Pancreatic Cancer and Pathogenic Variants in BRCA1, BRCA2, or PALB2 After Progression on Rucaparib. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 7 . Timothy J Brown, Arielle Yablonovitch, Jacob E Till, Jennifer Yen, Lesli A Kiedrowski, Ryan Hood, Mark H O'Hara, Ursina Teitelbaum, Thomas B Karasic, Charles Schneider, Erica L Carpenter, Katherine Nathanson, Susan M Domchek, Kim A Rei |
| Analysis of Plasma Circulating Tumor DNA in Borderline Resectable Pancreatic Cancer Treated with Neoadjuvant Modified FOLFIRINOX: Clinical Relevance of DNA Damage Repair Gene Alteration Detection. Cancer research and treatment 2023 5 . Dong-Hoon Lim, Hyunseok Yoon, Kyu-Pyo Kim, Baek-Yeol Ryoo, Sang Soo Lee, Do Hyun Park, Tae Jun Song, Dae Wook Hwang, Jae Hoon Lee, Ki Byung Song, Song Cheol Kim, Seung-Mo Hong, Jaewon Hyung, Changhoon Y |
| Prevalence and Risk Factors of Germline Pathogenic Variants in Pancreatic Ductal Adenocarcinoma. Cancer research and treatment 2023 4 . Ryu Kum Hei, Park Sunhwa, Chun Jung Won, Cho Eunhae, Choi Jongmun, Lee Dong-Eun, Shim Hyoeun, Kim Yun-Hee, Han Sung-Sik, Park Sang-Jae, Woo Sang Myung, Kong Sun-You |
| Pathogenic genomic alterations in Chinese pancreatic cancer patients and their therapeutical implications. Cancer medicine 2023 3 . Zhao Zhiming, Li Xiaomo, Wang Fei, Xu Yong, Liu Si, Han Quanli, Yang Zhiying, Huang Weiwei, Yin Zhuzeng, Liu Qu, Tan Haidong, Ma Tonghui, Si Shuang, Huang Jia, Yuan Hongling, Li Wei, Liu Ro |
| Germline mutations in homologous recombination repair genes among Chinese pancreatic ductal adenocarcinoma patients detected using next-generation sequencing. Molecular genetics & genomic medicine 2023 3 e2170. Jiang Huiqin, Huang Fei, Chen Xinning, Zhang Li, Shen Minna, Pan Baishen, Wang Beili, Guo W |
| Rare germline variants in pancreatic cancer and multiple primary cancers: an autopsy study. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2023 3 . Fujitani Hiroo, Eguchi Hidetaka, Kochi Yuta, Arai Tomio, Muramatsu Masaaki, Okazaki Yasus |
| [Pancreatic cancer screening in a clinical practice setting: it is the moment of Prevention]. Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru 2023 2 42 (4): 234-241. Adán-Merino Luisa, Mora-Soler Ana, Zaera-De la Fuente Celia, Garrido-Gallego Francisco, Crivillén-Anguita Olivia, Ponferrada-Diaz Áng |
| Prognostic and predictive value of tumoral DNA damage repair protein expression in patients with resected pancreatic cancer. Clinics and research in hepatology and gastroenterology 2023 2 47 (3): 102091. Ceylan Furkan, Guven Deniz Can, Taban Hakan, Aktepe Oktay, Sahin Taha Koray, Kilickap Sadettin, Turker Alev, Hamaloglu Erhan, Karakoc Derya, Isik Aynur, Akyol Aytekin, Yalcin Suayib, Dizdar Om |
| A systematic review and meta-analysis of germline BRCA mutations in pancreatic cancer patients identifies global and racial disparities in access to genetic testing. ESMO open 2023 2 8 (2): 100881. Paiella S, Azzolina D, Gregori D, Malleo G, Golan T, Simeone D M, Davis M B, Vacca P G, Crovetto A, Bassi C, Salvia R, Biankin A V, Casolino |
| [Familial pancreatic cancer syndrome]. Chirurgie (Heidelberg, Germany) 2023 2 . Seifert Lena, Weitz Jürg |
| Rate of Pathogenic Germline Variants in Patients With Lung Cancer. JCO precision oncology 2023 11 7 e2300190. Steven Sorscher, Jaclyn LoPiccolo, Brandie Heald, Elaine Chen, Sara L Bristow, Scott T Michalski, Sarah M Nielsen, Alix Lacoste, Emil Keyder, Hayan Lee, Robert L Nussbaum, Renato Martins, Edward D Espl |
| Prevalence of BRCA1 and BRCA2 germline variants in an unselected pancreatic cancer patient cohort in Pakistan. Hereditary cancer in clinical practice 2023 11 21 (1): 22. Noor Muhammad, Ayesha Azeem, Shumaila Arif, Humaira Naeemi, Iqra Masood, Usman Hassan, Bushra Ijaz, Faisal Hanif, Aamir Ali Syed, Muhammed Aasim Yusuf, Muhammad Usman Rash |
| Clinical characterization of patients with gBRCA1/2 mutation-positive unresectable pancreatic cancer: a multicenter prospective study. Japanese journal of clinical oncology 2023 10 . Tomohiro Kubo, Joji Muramatsu, Yohei Arihara, Ayako Murota, Kazuma Ishikawa, Makoto Yoshida, Hiroyuki Nagashima, Fumito Tamura, Yuki Ikeda, Makoto Usami, Michihiro Ono, Hajime Nakamura, Daichi Watanabe, Takanori Shibata, Kaoru Kasahara, Akihiro Sakurai, Kohichi Taka |
| Efficacy of olaparib in advanced cancers with germline or somatic mutations in BRCA1, BRCA2, CHEK2 and ATM, a Belgian Precision tumor-agnostic phase II study. ESMO open 2023 10 8 (6): 102041. S Joris, H Denys, J Collignon, M Rasschaert, D T'Kint de Roodenbeke, F P Duhoux, J-L Canon, S Tejpar, J Mebis, L Decoster, P Aftimos, J De Grè |
| Evaluation of inherited germline mutations in cancer susceptibility genes among pancreatic cancer patients: a single-center study. Molecular medicine (Cambridge, Mass.) 2023 1 29 (1): 14. Tavano Francesca, Gioffreda Domenica, Fontana Andrea, Palmieri Orazio, Gentile Annamaria, Latiano Tiziana, Latiano Anna, Latiano Tiziana Pia, Scaramuzzi Matteo, Maiello Evaristo, Bazzocchi Francesca, Perri Frances |
| Prevalence of germline variants in Brazilian pancreatic carcinoma patients. Scientific reports 2024 9 14 (1): 21083. Lívia Munhoz Rodrigues, Simone Maistro, Maria Lucia Hirata Katayama, Vinícius Marques Rocha, Rossana Veronica Mendoza Lopez, Edia Filomena di Tullio Lopes, Fernanda Toledo Gonçalves, Cintia Fridman, Pedro Adolpho de Menezes Pacheco Serio, Luciana Rodrigues Carvalho Barros, Luiz Antonio Senna Leite, Vanderlei Segatelli, Maria Del Pilar Estevez-Diz, Rodrigo Santa Cruz Guindalini, Ulysses Ribeiro Junior, Maria Aparecida Azevedo Koike Folguei |
| Prevalence of KRAS amplification in patients with metastatic cancer: Real-world next-generation sequencing analysis. Pathology, research and practice 2024 8 261 155473. Dae-Ho Choi, Hye-Lim Jang, Sung Hee Lim, Seung Tae Kim, Jung Yong Hong, Se Hoon Park, Joon Oh Park, Deok Geun Kim, Kyoung-Mee Kim, Jeeyun L |
| The guidelines for clinical practice for carriers of germline mutations in hereditary breast, ovarian, prostate, and pancreatic cancer predisposition genes BRCA1, BRCA2, PALB2, ATM, and CHEK2 (4.2024). Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti 2024 8 38 (4): 292-299. P Kleiblová, J Novotný, D Cibula, V Curtisová, O Dubová, L Foretová, A Germanová, M Janatová, O Havránek, M Hojsáková, M Hudcová, M Koudová, V Krutílková, M Palacova, S Paulich, K Petrakova, J Presl, A Puchmajerová, J Soukupová, M Šenke?íková, Z Šimková, H Št?pánková, I Šubrt, I Tachecí, P Tesner, O Urban, K Veselá, Š Vilímová, Z Vl?ková, M Vo?ka, V Weinberger, M Zikán, M Zimovjanová, Z Klei |
| Clinical significance of germline breast cancer susceptibility gene (gBRCA) testing and olaparib as maintenance therapy for patients with pancreatic cancer. BMC cancer 2024 8 24 (1): 1000. Yasuharu Kawamoto, Takuo Yamai, Kenji Ikezawa, Yusuke Seiki, Ko Watsuji, Takeru Hirao, Makiko Urabe, Yugo Kai, Ryoji Takada, Kaori Mukai, Tasuku Nakabori, Hiroyuki Uehara, Tazuko Inoue, Fumie Fujisawa, Kazuyoshi Ohka |
| Germline pathogenic variants of cancer predisposition genes in a multicentre Italian cohort of pancreatic cancer patients. European journal of cancer (Oxford, England : 1990) 2024 7 208 114226. Giulia Orsi, Catia Carconi, Paola Ghiorzo, Paola Carrera, Lorenza Pastorino, Silvia Presi, Marta Chiaravalli, Elena Barbieri, Guido Giordano, Stefania Sciallero, Alberto Puccini, Lisa Salvatore, Laura Cortesi, Marina Macchini, Maria Iole Natalicchio, Eleonora Allavena, Chiara Pirrone, Livia Archibugi, Bruna Dalmasso, William Bruno, Giampaolo Tortora, Matteo Landriscina, Gabriele Capurso, Stefano Cascinu, Massimo Falconi, Michele Re |
| Digenic Inheritance of Mutations in Homologous Recombination Genes in Cancer Patients. Journal of personalized medicine 2024 6 14 (6): . Maria Valeria Freire, Marie Martin, Karin Segers, Edith Sepulchre, Natacha Leroi, Jérôme Coupier, Hassan Rezaei Kalantari, Pascal Wolter, Joëlle Collignon, Marc Polus, Olivier Plomteux, Claire Josse, Vincent Bou |
| Identification of RAD17 as a candidate cancer predisposition gene in families with histories of pancreatic and breast cancers. BMC cancer 2024 6 24 (1): 723. Sofie Joris, Philippe Giron, Catharina Olsen, Sara Seneca, Alexander Gheldof, Shula Staessens, Rajendra Bahadur Shahi, Sylvia De Brakeleer, Erik Teugels, Jacques De Grève, Frederik J H |
| Germline Pathogenic Variants in Patients With Pancreatic and Periampullary Cancers. JCO precision oncology 2024 5 8 e2400101. Yohei Ando, Mohamad Dbouk, Takeichi Yoshida, Elizabeth Abou Diwan, Helena Saba, Ali Dbouk, Kanako Yoshida, Nicholas J Roberts, Alison P Klein, Richard Burkhart, Jin He, Ralph H Hruban, Michael Goggi |
| The Use of Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus Does Not Increase the Risk of Pancreatic Cancer: A U.S.-Based Cohort Study. Cancers 2024 5 16 (9): . Mark Ayoub, Carol Faris, Tajana Juranovic, Harleen Chela, Ebubekir Daglil |
| A MALDI-TOF mass spectrometry-based method for detection of copy number variations in BRCA1 and BRCA2 genes. Frontiers in molecular biosciences 2024 1 10 1301652. Hongjun Zhou, Xin He, Jiadong Zhao, Zhu Mei, Xiayan Zhang, Wen Yuan, Hui Do |
- Page last reviewed:Feb 1, 2024
- Content source: